Liver cirrhosis in chronic HCV infection is an independent predictor of poor response to IFN-α and RBV therapy [40], but there is no explanation why cirrhotic patients show less viral clearance with IFN-α and RBV combination therapy. Here, IFNA1 is linked to cirrhosis of liver.